Page last updated: 2024-10-29

ketamine and Ileus

ketamine has been researched along with Ileus in 2 studies

Ketamine: A cyclohexanone derivative used for induction of anesthesia. Its mechanism of action is not well understood, but ketamine can block NMDA receptors (RECEPTORS, N-METHYL-D-ASPARTATE) and may interact with sigma receptors.
ketamine : A member of the class of cyclohexanones in which one of the hydrogens at position 2 is substituted by a 2-chlorophenyl group, while the other is substituted by a methylamino group.

Ileus: A condition caused by the lack of intestinal PERISTALSIS or INTESTINAL MOTILITY without any mechanical obstruction. This interference of the flow of INTESTINAL CONTENTS often leads to INTESTINAL OBSTRUCTION. Ileus may be classified into postoperative, inflammatory, metabolic, neurogenic, and drug-induced.

Research Excerpts

ExcerptRelevanceReference
"Ketamine did not prevent LPS induced gastrointestinal ileus, nor did it improve gastric emptying."3.73Ketamine inhibits lipopolysacharide (LPS) induced gastric luminal fluid accumulation. ( Gonzalez, EA; Mercer, DW; Moore, FA; Moore-Olufemi, SD; Suliburk, JW; Weisbrodt, N, 2005)
"Ketamine is a hypnotic pharmacon with high analgesic potency."1.33[Intravenous S-+-ketamine for treatment of visceral pain in the final phase]. ( Hartmann, W; Weixler, D, 2006)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Suliburk, JW1
Gonzalez, EA1
Moore-Olufemi, SD1
Weisbrodt, N1
Moore, FA1
Mercer, DW1
Weixler, D1
Hartmann, W1

Other Studies

2 other studies available for ketamine and Ileus

ArticleYear
Ketamine inhibits lipopolysacharide (LPS) induced gastric luminal fluid accumulation.
    The Journal of surgical research, 2005, Volume: 127, Issue:2

    Topics: Animals; Anti-Inflammatory Agents; Blotting, Western; Body Fluids; Gastric Emptying; Gastric Mucosa;

2005
[Intravenous S-+-ketamine for treatment of visceral pain in the final phase].
    Wiener medizinische Wochenschrift (1946), 2006, Volume: 156, Issue:9-10

    Topics: Abdominal Pain; Adenocarcinoma; Analgesics; Cecal Neoplasms; Dose-Response Relationship, Drug; Drug

2006